BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Daiichi Sankyo
Fish and Richardson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,251,426

« Back to Dashboard

Which drugs does patent 6,251,426 protect, and when does it expire?

Patent 6,251,426 protects MIDOL LIQUID GELS and is included in one NDA.

This patent has nine patent family members in eight countries.

Summary for Patent: 6,251,426

Title: Ibuprofen-containing softgels
Abstract:Liquid softgel fill formulations containing ibuprofen in free acid form, and softgel capsules comprised of a gelatin sheath enclosing such fill formulations, are prepared by dissolving more than 30% of ibuprofen in free acid form in polyethylene glycol and at least 10% by weight of a polyvinylpyrrolidone having an average molecular weight of from about 2,000 to about 54,000. The formulations may also include a surfactant to increase the bioavailability of the ibuprofen.
Inventor(s): Gullapalli; Rampurna Prasad (Greensboro, NC)
Assignee: Banner Pharmacaps, Inc. (High Point, NC)
Application Number:09/389,003
Patent Claim Types:
see list of patent claims
Formulation; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bionpharma Inc
CAPSULE;ORAL021472-001Oct 18, 2002OTCYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 6,251,426

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2003508434► Subscribe
European Patent Office1207872► Subscribe
Germany60034044► Subscribe
Canada2382292► Subscribe
Australia780212► Subscribe
Australia7094900► Subscribe
Austria357229► Subscribe
Poland362850► Subscribe
World Intellectual Property Organization (WIPO)0115688► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus